News Interim report for the first nine months of 2022 Please read the full announcement in PDF Attachment 2022_27_Q32022_CompanyAnnouncement Continue Reading Previous Addex Therapeutics to Report Third Quarter 2022 Financial Results and Host Conference Call on November 11, 2022Next APEIRON Respiratory Therapies announces positive results from Phase I trial of inhaled APN01 Related Stories AI Agents News Security New Cequence & EMA Research: 94% of Enterprises Trust Their AI Agents Aren’t Over-Provisioned. Only 33% Actually Enforce It. News CENTRESTAGE ELITES presents KIT WAN STUDIOS, A star-studded fashion extravaganza features sci-fi aesthetics with over 30 new creations News China-aided Laos’ first integrated photovoltaic-storage-charging ‘zero-carbon library’ opens News Asia’s premier fashion event CENTRESTAGE officially kicks off News Radisson Continues to Intersect High-Grade Gold Mineralization in the “Trend 1-Trend 2 Gap” at O’Brien, Including 52.34 g/t Gold over 3 Metres News Galaxy Group (Nasdaq: GLXG) Announces Support for Stablecoin Payments for Businesses, Employees and Contractors Starting September 2026